Orion OYJ Total Liabilities and Share Holders Equity 2017-2024 | ORINY

Orion OYJ total liabilities and share holders equity from 2017 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Orion OYJ total liabilities and share holders equity for the quarter ending June 30, 2024 was $1.569B, a 10.04% increase year-over-year.
  • Orion OYJ total liabilities and share holders equity for 2023 was $1.557B, a 1.72% decline from 2022.
  • Orion OYJ total liabilities and share holders equity for 2022 was $1.584B, a 20.2% increase from 2021.
  • Orion OYJ total liabilities and share holders equity for 2021 was $1.318B, a 3.42% increase from 2020.
Orion OYJ Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $1,557
2022 $1,584
2021 $1,318
2020 $1,274
2019 $1,160
2018 $1,354
2017 $1,193
2016 $1,176
Orion OYJ Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-06-30 $1,569
2024-03-31 $1,586
2023-12-31 $1,557
2023-09-30 $1,493
2023-06-30 $1,426
2023-03-31 $1,387
2022-12-31 $1,584
2022-09-30 $1,579
2022-06-30 $1,352
2022-03-31 $1,374
2021-12-31 $1,318
2021-09-30 $1,245
2021-06-30 $1,255
2021-03-31 $1,429
2020-12-31 $1,274
2020-09-30 $1,286
2020-06-30 $1,218
2020-03-31 $1,372
2019-12-31 $1,160
2019-09-30 $1,037
2019-06-30 $1,010
2019-03-31 $1,363
2018-12-31 $1,354
2018-09-30 $1,266
2018-06-30 $1,280
2018-03-31 $1,249
2017-12-31 $1,193
2017-09-30 $1,140
2017-06-30 $1,042
2017-03-31 $999
2016-12-31 $1,176
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.653B $1.288B
Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company's core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.485B 30.20
Takeda Pharmaceutical (TAK) Japan $43.083B 8.97
Merck (MKKGY) Germany $20.756B 22.65
Astellas Pharma (ALPMY) Japan $19.764B 18.20
Sandoz Group AG (SDZNY) Switzerland $19.412B 0.00
United Therapeutics (UTHR) United States $17.897B 17.60
Summit Therapeutics (SMMT) United States $15.309B 0.00
Neurocrine Biosciences (NBIX) United States $12.859B 34.05
Shionogi (SGIOY) Japan $12.188B 11.68
Catalent (CTLT) United States $10.755B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.722B 7.55
Madrigal Pharmaceuticals (MDGL) United States $7.395B 0.00
Corcept Therapeutics (CORT) United States $6.055B 45.87
Ionis Pharmaceuticals (IONS) United States $5.964B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.704B 0.00
PTC Therapeutics (PTCT) United States $3.441B 0.00
Dyne Therapeutics (DYN) United States $2.945B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.863B 17.13
Catalyst Pharmaceuticals (CPRX) United States $2.748B 12.45
Arrowhead Pharmaceuticals (ARWR) United States $2.674B 0.00
Soleno Therapeutics (SLNO) United States $2.471B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.229B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.131B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.926B 0.00
Harrow (HROW) United States $1.771B 0.00
Xencor (XNCR) United States $1.659B 0.00
Ocular Therapeutix (OCUL) United States $1.653B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.620B 0.00
ARS Pharmaceuticals (SPRY) United States $1.610B 0.00
Evotec AG (EVO) Germany $1.573B 0.00
Indivior (INDV) United States $1.404B 5.72
Guardian Pharmacy Services (GRDN) United States $1.377B 0.00
Enliven Therapeutics (ELVN) United States $1.283B 0.00
Cassava Sciences (SAVA) United States $1.269B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.266B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.200B 0.00
Ardelyx (ARDX) United States $1.087B 0.00
Collegium Pharmaceutical (COLL) United States $1.013B 5.53
Bioventus (BVS) United States $0.959B 30.36
Cronos Group (CRON) Canada $0.864B 0.00
Relay Therapeutics (RLAY) United States $0.795B 0.00
USANA Health Sciences (USNA) United States $0.772B 14.32
Exscientia (EXAI) United Kingdom $0.739B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.702B 0.00
Altimmune (ALT) United States $0.674B 0.00
Tourmaline Bio (TRML) United States $0.671B 0.00
Savara (SVRA) United States $0.630B 0.00
Korro Bio (KRRO) United States $0.606B 0.00
Elite Pharmaceuticals (ELTP) United States $0.598B 56.01
ProKidney (PROK) United States $0.594B 0.00
Larimar Therapeutics (LRMR) United States $0.577B 0.00
Verve Therapeutics (VERV) United States $0.543B 0.00
OmniAb (OABI) United States $0.531B 0.00
Siga Technologies (SIGA) United States $0.504B 5.88
Silence Therapeutics (SLN) United Kingdom $0.485B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.479B 194.43
Esperion Therapeutics (ESPR) United States $0.479B 0.00
Xeris Biopharma Holdings (XERS) United States $0.470B 0.00
KalVista Pharmaceuticals (KALV) United States $0.461B 0.00
Organogenesis (ORGO) United States $0.457B 0.00
Aquestive Therapeutics (AQST) United States $0.455B 0.00
Zevra Therapeutics (ZVRA) United States $0.451B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.436B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.428B 0.00
Akebia Therapeutics (AKBA) United States $0.425B 0.00
4D Molecular Therapeutics (FDMT) United States $0.409B 0.00
Sage Therapeutics (SAGE) United States $0.351B 0.00
Avita Medical (RCEL) United States $0.332B 0.00
Lyell Immunopharma (LYEL) United States $0.325B 0.00
Nature's Sunshine Products (NATR) United States $0.303B 18.05
Aldeyra Therapeutics (ALDX) United States $0.283B 0.00
Pyxis Oncology (PYXS) United States $0.275B 0.00
Acrivon Therapeutics (ACRV) United States $0.260B 0.00
Lexeo Therapeutics (LXEO) United States $0.254B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.226B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.219B 0.00
Profound Medical (PROF) Canada $0.196B 0.00
Heron Therapeutics (HRTX) United States $0.194B 0.00
Nanobiotix S.A (NBTX) France $0.190B 0.00
Galectin Therapeutics (GALT) United States $0.184B 0.00
Incannex Healthcare (IXHL) Australia $0.184B 0.00
Aclaris Therapeutics (ACRS) United States $0.183B 0.00
MediWound (MDWD) Israel $0.182B 0.00
Achieve Life Sciences (ACHV) Canada $0.160B 0.00
Context Therapeutics (CNTX) United States $0.154B 0.00
Cardiol Therapeutics (CRDL) Canada $0.153B 0.00
CytoDyn (CYDY) United States $0.152B 0.00
VAXART, INC (VXRT) United States $0.128B 0.00
Telomir Pharmaceuticals (TELO) United States $0.124B 0.00
Century Therapeutics (IPSC) United States $0.120B 0.00
Fractyl Health (GUTS) United States $0.116B 0.00
Journey Medical (DERM) United States $0.113B 0.00
Karyopharm Therapeutics (KPTI) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Regulus Therapeutics (RGLS) United States $0.102B 0.00
Relmada Therapeutics (RLMD) United States $0.100B 0.00
Arch Biopartners (ACHFF) Canada $0.094B 0.00
OptiNose (OPTN) United States $0.090B 0.00
Citius Pharmaceuticals (CTXR) United States $0.087B 0.00
CASI Pharmaceuticals (CASI) China $0.087B 0.00
PMV Pharmaceuticals (PMVP) United States $0.086B 0.00
Metagenomi (MGX) United States $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Assertio Holdings (ASRT) United States $0.081B 21.30
ElectroCore (ECOR) United States $0.080B 0.00
Inotiv (NOTV) United States $0.079B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 369.00
Vivani Medical (VANI) United States $0.069B 0.00
Prelude Therapeutics (PRLD) United States $0.063B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
AlloVir (ALVR) United States $0.062B 0.00
Mural Oncology (MURA) Ireland $0.060B 0.00
Nutriband (NTRB) United States $0.056B 0.00
Protara Therapeutics (TARA) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
SCYNEXIS (SCYX) United States $0.051B 0.00
Rafael Holdings (RFL) United States $0.046B 0.00
Unicycive Therapeutics (UNCY) United States $0.046B 0.00
VYNE Therapeutics (VYNE) United States $0.044B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.042B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
CERo Therapeutics Holdings (CERO) United States $0.040B 0.00
DURECT (DRRX) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
BioLineRx (BLRX) Israel $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.034B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Oruka Therapeutics (ORKA) United States $0.032B 0.00
BioVie (BIVI) United States $0.031B 0.00
Lipocine (LPCN) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
GlycoMimetics (GLYC) United States $0.026B 0.00
Inhibikase Therapeutics (IKT) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.021B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.020B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.019B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Talphera (TLPH) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.015B 0.00
Scienture Holdings (SCNX) United States $0.015B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
NRx Pharmaceuticals (NRXP) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Indaptus Therapeutics (INDP) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Dominari Holdings (DOMH) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Redhill Biopharma (RDHL) Israel $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.08
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Phio Pharmaceuticals (PHIO) United States $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 1.87
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 40.69